Amylyx Pharmaceuticals, Inc. — All Filings
397 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
4/A
424B4
424B5
5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POSASR
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-000598 | Mar 26, 2026 | — |
| 8-K | 8-K | 0001193125-26-120691 | Mar 24, 2026 | — |
| 4 | 4 | 0001193125-26-098440 | Mar 9, 2026 | Mar 5, 2026 |
| 4 | 4 | 0001193125-26-098439 | Mar 9, 2026 | Mar 5, 2026 |
| 4 | 4 | 0001193125-26-098438 | Mar 9, 2026 | Mar 5, 2026 |
| 4 | 4 | 0001193125-26-098437 | Mar 9, 2026 | Mar 5, 2026 |
| 4 | 4 | 0001193125-26-098436 | Mar 9, 2026 | Mar 5, 2026 |
| 4 | 4 | 0001193125-26-091443 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001193125-26-091442 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001193125-26-091440 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001193125-26-091438 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001193125-26-091436 | Mar 4, 2026 | Mar 2, 2026 |
| S-8 | S-8 | 0001193125-26-088117 | Mar 3, 2026 | — |
| S-3ASR | S-3ASR | 0001193125-26-086735 | Mar 3, 2026 | — |
| 10-K | 10-K | 0001193125-26-086645 | Mar 3, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-086629 | Mar 3, 2026 | — |
| 144 | — | 0001898314-26-000002 | Mar 2, 2026 | — |
| 144 | — | 0001326969-26-000002 | Mar 2, 2026 | — |
| 144 | — | 0001235598-26-000002 | Mar 2, 2026 | — |
| 144 | — | 0001913765-26-000002 | Mar 2, 2026 | — |
| 144 | — | 0001898644-26-000002 | Mar 2, 2026 | — |
| 4 | 4 | 0001193125-26-071460 | Feb 25, 2026 | Feb 23, 2026 |
| 144 | — | 0001193125-26-064078 | Feb 23, 2026 | — |
| SCHEDULE 13G/A | — | 0001193125-26-054741 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0000902664-26-000907 | Feb 12, 2026 | — |
| SCHEDULE 13G/A | — | 0000315066-26-000374 | Feb 5, 2026 | — |
| 4 | 4 | 0001193125-26-037553 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | 4 | 0001193125-26-037552 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | 4 | 0001193125-26-037548 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | 4 | 0001193125-26-037544 | Feb 4, 2026 | Feb 2, 2026 |
| 144 | — | 0001193125-26-033641 | Feb 2, 2026 | — |
| 144 | — | 0001193125-26-033640 | Feb 2, 2026 | — |
| 144 | — | 0001193125-26-033639 | Feb 2, 2026 | — |
| 144 | — | 0001193125-26-033638 | Feb 2, 2026 | — |
| SCHEDULE 13G | — | 0000102909-26-000077 | Jan 30, 2026 | — |
| SCHEDULE 13G/A | — | 0002012383-26-000638 | Jan 21, 2026 | — |
| 4 | 4 | 0001193125-26-017057 | Jan 20, 2026 | Jan 15, 2026 |
| 4 | 4 | 0001193125-26-017056 | Jan 20, 2026 | Jan 15, 2026 |
| 144 | — | 0001950047-26-000500 | Jan 16, 2026 | — |
| 144 | — | 0001950047-26-000499 | Jan 16, 2026 | — |
| 144 | — | 0001950047-26-000451 | Jan 15, 2026 | — |
| 144 | — | 0001950047-26-000449 | Jan 15, 2026 | — |
| 4 | 4 | 0001193125-26-012921 | Jan 14, 2026 | Jan 12, 2026 |
| 4 | 4 | 0001193125-26-007669 | Jan 8, 2026 | Jan 6, 2026 |
| 4 | 4 | 0001193125-26-007666 | Jan 8, 2026 | Jan 6, 2026 |
| 4 | 4 | 0001193125-26-007664 | Jan 8, 2026 | Jan 6, 2026 |
| 8-K | 8-K | 0001193125-26-006991 | Jan 8, 2026 | — |
| 144 | — | 0001193125-26-004407 | Jan 6, 2026 | — |
| 144 | — | 0001193125-26-004404 | Jan 6, 2026 | — |
| 144 | — | 0001193125-26-004394 | Jan 6, 2026 | — |